RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law Most people hear not FDA approved and immediately think unsafe or ineffective but the reality is a lot more about economics than science. If something can't be patented, there's little incentive to